HALO earnings date and history (2026)
Halozyme Therapeutics Inc. (HALO) next reports earnings on Mon Nov 2. Analysts expect EPS of $2.13 (2 estimates), against $1.63 in the same quarter a year ago. Last time, on Thu Aug 6, it reported $2.17 against a $1.73 consensus (+25.4%). Not investment advice.
See every company reporting on the earnings calendar or the filed financial statements.
Past reports#
Newest first. The surprise is the reported EPS against the consensus going in, in percent; the move is the stock’s close-to-close change over the first session that could trade on the report, shown once that session has settled and only where the report’s session is known.
| Date | Est | Actual | Move |
|---|---|---|---|
| Aug 6, 2026 | $1.73 | $2.17 | — |
| May 11, 2026 | $1.46 | $1.48 | — |
| Feb 17, 2026 | $2.07 | -$0.35 | — |
| Nov 3, 2025 | $1.54 | $1.63 | — |
About this data
Report dates, sessions, consensus EPS estimates, reported EPS and surprises come from Nasdaq's public earnings calendar and analyst pages, read daily; they are estimates, subject to change, and may not be accurate. A quarter the calendar saw is shown with its session; a quarter known only from the analyst page has none, and its move is left blank rather than guessed, because a pre-open and an after-close report trade on different sessions. The move is ChartRow's own: the first settled close that could trade on the report over the close before it, price return. Not investment advice.
FAQ#
- When does HALO report earnings?
- HALO is scheduled to report on Mon Nov 2, according to Nasdaq's earnings calendar. Dates are set by the company and can move.
- What EPS is expected from HALO?
- The consensus estimate is $2.13 a share across 2 analysts; the same quarter a year ago came in at $1.63.
- Did HALO beat earnings last quarter?
- Yes: on Thu Aug 6 HALO reported $2.17 against a $1.73 consensus, a +25.4% surprise.